181 related articles for article (PubMed ID: 11239184)
1. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.
Grotta JC; Welch KM; Fagan SC; Lu M; Frankel MR; Brott T; Levine SR; Lyden PD
Stroke; 2001 Mar; 32(3):661-8. PubMed ID: 11239184
[TBL] [Abstract][Full Text] [Related]
2. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
3. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
Brown DL; Johnston KC; Wagner DP; Haley EC
Stroke; 2004 Jan; 35(1):147-50. PubMed ID: 14657446
[TBL] [Abstract][Full Text] [Related]
4. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.
Saqqur M; Molina CA; Salam A; Siddiqui M; Ribo M; Uchino K; Calleja S; Garami Z; Khan K; Akhtar N; O'Rourke F; Shuaib A; Demchuk AM; Alexandrov AV;
Stroke; 2007 Jan; 38(1):69-74. PubMed ID: 17138949
[TBL] [Abstract][Full Text] [Related]
5. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
[TBL] [Abstract][Full Text] [Related]
6. Acute Ischemic Stroke with Very Early Clinical Improvement: A National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trials Exploratory Analysis.
Balucani C; Levine SR; Khoury JC; Khatri P; Saver JL; Broderick JP
J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):894-901. PubMed ID: 26825352
[TBL] [Abstract][Full Text] [Related]
7. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
[TBL] [Abstract][Full Text] [Related]
8. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
Alexandrov AV; Grotta JC
Neurology; 2002 Sep; 59(6):862-7. PubMed ID: 12297567
[TBL] [Abstract][Full Text] [Related]
9. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
IMS Study Investigators
Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
[TBL] [Abstract][Full Text] [Related]
10. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.
Bruno A; Levine SR; Frankel MR; Brott TG; Lin Y; Tilley BC; Lyden PD; Broderick JP; Kwiatkowski TG; Fineberg SE;
Neurology; 2002 Sep; 59(5):669-74. PubMed ID: 12221155
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 2000 Dec; 31(12):2912-9. PubMed ID: 11108748
[TBL] [Abstract][Full Text] [Related]
12. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
[TBL] [Abstract][Full Text] [Related]
13. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
14. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
Nichols C; Khoury J; Brott T; Broderick J
J Stroke Cerebrovasc Dis; 2008; 17(2):64-8. PubMed ID: 18346647
[TBL] [Abstract][Full Text] [Related]
15. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
16. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
Marler JR; Tilley BC; Lu M; Brott TG; Lyden PC; Grotta JC; Broderick JP; Levine SR; Frankel MP; Horowitz SH; Haley EC; Lewandowski CA; Kwiatkowski TP
Neurology; 2000 Dec; 55(11):1649-55. PubMed ID: 11113218
[TBL] [Abstract][Full Text] [Related]
17. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
18. Hemorrhage in the Interventional Management of Stroke study.
IMS Study Investigators
Stroke; 2006 Mar; 37(3):847-51. PubMed ID: 16439694
[TBL] [Abstract][Full Text] [Related]
19. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
Awadh M; MacDougall N; Santosh C; Teasdale E; Baird T; Muir KW
Stroke; 2010 Sep; 41(9):1990-5. PubMed ID: 20705933
[TBL] [Abstract][Full Text] [Related]
20. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
